MIDAZOLAM

Generic: MIDAZOLAM HYDROCHLORIDE

HospiraManufacturer
INTRAMUSCULAR, INTRAVENOUSRoute
MIDAZOLAM HYDROCHLORIDEActive Substance
2000-06-20Original Approval

MIDAZOLAM is FDA application ANDA075293, sponsored by HOSPIRA. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.

Recalls

Top Reported Reactions

1
DRUG INEFFECTIVE
3,477 reports
2
OFF LABEL USE
2,614 reports
3
HYPOTENSION
1,627 reports
4
DRUG INTERACTION
1,261 reports
5
SEIZURE
1,229 reports
6
PYREXIA
978 reports
7
TOXICITY TO VARIOUS AGENTS
954 reports
8
CARDIAC ARREST
950 reports
9
ACUTE KIDNEY INJURY
946 reports
10
DEATH
742 reports